Dr Reddys Laboratories Share Price Today - Live Blog for July 17, 2025

Dr Reddys Laboratories Ltd experienced a substantial 0.10% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,265.15, making it an appealing option for investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.15% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,264.95 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.13%, and it's currently trading at ₹1,262.25. The stock maintains a PE of 18.6100, while the industry PE is 35.5895, prompting discussions about its valuation.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.37% in its share price, and it currently trades at ₹1,263.90 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.07% dip in its share price and is currently trading at ₹1,268.65. The stock has a PE ratio of 18.6100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.00% boost, with the current market value at ₹1,269.95 per share. This surge has not gone unnoticed by investors.

With a -0.05% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,269.85. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.6100, while the industry PE is 35.5895.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.10%, reaching the current market price of ₹1,271.00. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

With a remarkable 0.07% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,269.75. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.6100, while the industry's PE ratio is 35.5895.

The stock of Dr Reddys Laboratories Ltd suffered a -0.10% drop, and it's now trading at ₹1,268.90 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd is facing a -0.09% decline and is currently trading at ₹1,270.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.02%, and as of now, it's trading at ₹1,271.35 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.21%, and it is currently trading at ₹1,271.05. Additionally, the stock maintains a PE ratio of 18.6100, while the industry PE is 35.5895.

Dr Reddys Laboratories Ltd share price surged by 0.08%. With its current market price standing at ₹1,265.60 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's stock has surged by 0.08%, and it is currently trading at ₹1,265.60. Additionally, the stock maintains a PE ratio of 18.6100, while the industry PE is 35.5895.

After a significant 0.10% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,264.55 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's stock price surged by 0.16%, reaching the current market value of ₹1,263.10 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.15%, reaching a current market price of ₹1,261.10. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a significant 0.14% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,261.70 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd share price has declined by -0.00%, and it's currently trading at ₹1,259.95. The stock maintains a PE of 18.6100, while the industry PE is 35.5895, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's share price rallied by 0.10%, reaching the current market price of ₹1,260.00. This surge is indicative of the stock's recent positive performance.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.06% in its share price, and it currently trades at ₹1,258.70 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price surged by 0.07%. With its current market price standing at ₹1,259.50 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd witnessed a -0.05% drop in its share price and is currently trading at ₹1,258.75. With the stock's PE at 18.6100 and the industry PE at 35.5895, investors are weighing their options.

With a -0.33% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,259.40. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.6100, while the industry PE is 35.5895.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.46% uptick in its share price. As a result, it's now actively trading at ₹1,265.40 per share, making it an attractive option for investors.